56.2 Chronic Venous Insufficiency, Stasis Dermatitis & Lymphedema

ABFM Family Medicine Certification Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Exam Structure, Blueprint & Clinical Decision-Making

1.1 Exam Blueprint, FMCLA vs. One-Day Exam & Board Scoring 1.2 Clinical Reasoning, Test-Taking Strategy & Ambiguity Management 1.3 Evidence-Based Medicine & Clinical Practice Guidelines in Primary Care

2 Chapter 2: Healthcare Systems, Practice Management & Quality

2.1 Practice Management, Billing, Coding & Documentation 2.2 Quality Improvement, Patient Safety & Diagnostic Stewardship 2.3 Interprofessional Team-Based Care & Care Coordination

3 Chapter 3: Ethics, Law, Biostatistics & Health Equity

3.1 Medical Ethics, Informed Consent & Surrogate Decision-Making 3.2 Biostatistics, Clinical Epidemiology & Diagnostic Test Interpretation 3.3 Social Determinants of Health, Health Equity & Cultural Humility 3.4 Physician Wellness, Burnout Prevention & Professionalism

4 Chapter 4: Lifestyle Counseling & Behavior Change

4.1 Alcohol Use Screening & Brief Intervention 4.2 Illicit Drug & Cannabis Counseling 4.3 Tobacco & Vaping Cessation Counseling

5 Chapter 5: Nutrition, Physical Activity & Chronic Disease Prevention

5.1 Dietary Counseling for Obesity & Chronic Disease Prevention 5.2 Exercise Prescription & Physical Activity Counseling 5.3 Genetic Risk Assessment & Family History Counseling

6 Chapter 6: Routine Adult Immunizations

6.1 ACIP Adult Respiratory Vaccines: Influenza, COVID-19, RSV & Pneumococcal 6.2 ACIP Adult Non-Respiratory Vaccines: Tdap, Shingrix, HPV & Hep B 6.3 Immunizations in Special Populations: Pregnancy, Asplenia & Immunocompromise

7 Chapter 7: Pediatric Health Maintenance & Surveillance

7.1 Newborn Examination & Early Postnatal Care 7.2 Well-Child Care, Developmental Surveillance & Milestones 7.3 Pediatric & Adolescent Screening: Vision, Hearing, Anemia & Lead 7.4 Pediatric Oral Health, Dental Screening & Fluoride

8 Chapter 8: Behavioral Health & Safety Screening

8.1 Primary Care Depression, Anxiety & Behavioral Health Screening 8.2 Domestic Violence, Intimate Partner Violence & Firearm Safety 8.3 Occupational Health & Recreational Safety Counseling

9 Chapter 9: Adult Preventive Screening: Cardiovascular & Metabolic

9.1 Cardiovascular Disease & Hypertension Screening 9.2 Type 2 Diabetes Screening & Prediabetes Risk Stratification 9.3 Abdominal Aortic Aneurysm & Osteoporosis Screening

10 Chapter 10: Adult Cancer Screening: Breast & Gynecologic

10.1 Breast Cancer Screening & Risk-Assessment 10.2 Cervical Cancer Screening & ASCCP Algorithms 10.3 Skin Cancer Clinical Assessment & Counseling

11 Chapter 11: Adult Cancer Screening: Colorectal, Lung & Prostate

11.1 Colorectal Cancer Screening Modalities & Intervals 11.2 Lung Cancer Screening with Low-Dose CT 11.3 Prostate Cancer Screening & Shared Decision-Making

12 Chapter 12: Sexual Health, Infectious Disease Screening & Contraception

12.1 Sexual Health Counseling & Risk-Reduction Strategies 12.2 STI Screening: Chlamydia, Gonorrhea, Syphilis & Trichomoniasis 12.3 Bloodborne Infectious Disease Screening: HIV & Hepatitis C

13 Chapter 13: Reproductive Life Planning, Lactation & Preoperative Care

13.1 Preconception Planning & Comprehensive Contraception Management 13.2 Lactation Support & Breastfeeding Counseling 13.3 Preoperative Medical Evaluation & Pre-Participation Sports Exam

14 Chapter 14: Emergent Cardiovascular Conditions

14.1 Acute Coronary Syndromes & Myocardial Infarction 14.2 Acute Chest Pain Risk Stratification & Triage 14.3 Acute or Critical Valvular Heart Emergencies

15 Chapter 15: Cardiac Arrhythmias, Heart Failure & Hypertensive Crises

15.1 Acute Atrial & Ventricular Arrhythmias 15.2 Acute Decompensated Heart Failure & Cardiogenic Shock 15.3 Hypertensive Emergency & Urgency Management

16 Chapter 16: Vascular & Thromboembolic Emergencies

16.1 Pulmonary Embolism & Deep Vein Thrombosis 16.2 Acute Aortic Syndromes & Peripheral Vascular Emergencies 16.3 Critical Limb Ischemia & Acute Arterial Occlusion

17 Chapter 17: Neurologic Emergencies: Stroke & Altered Consciousness

17.1 Acute Ischemic Stroke & Intracranial Hemorrhage 17.2 Syncope Evaluation & Status Epilepticus 17.3 Acute Delirium, Encephalopathy & Severe Confusion

18 Chapter 18: Neurologic Trauma & Acute Cranial Emergencies

18.1 Concussion, Moderate-to-Severe TBI & Intracranial Injury 18.2 Thunderclap & Acute Severe Secondary Headaches 18.3 Acute Ophthalmologic Emergencies

19 Chapter 19: Acute Abdominal, Pelvic & Gastrointestinal Emergencies

19.1 Acute Abdominal & Pelvic Pain Triage 19.2 Upper & Lower Gastrointestinal Bleeding 19.3 Acute Hepatic Failure, Cholangitis & Severe Jaundice

20 Chapter 20: Acute Pulmonary & Airway Emergencies

20.1 Acute Hypoxic Respiratory Failure & ARDS 20.2 Severe Community-Acquired Pneumonia & Empyema 20.3 Acute Severe Epistaxis & Airway Obstruction

21 Chapter 21: Acute Traumatic Injuries & Wound Care

21.1 Major Trauma Resuscitation & Initial Assessment 21.2 Burn Assessment, Inhalation Injury & Resuscitation 21.3 Laceration Management, Complex Wounds & Animal Bites

22 Chapter 22: Acute Orthopedic & Musculoskeletal Emergencies

22.1 Acute Ambulatory Fractures & Initial Splinting 22.2 Compartment Syndrome & Major Orthopedic Trauma 22.3 Septic Arthritis & Acute Microcrystalline Crises

23 Chapter 23: Severe Infections, Sepsis & Systemic Emergencies

23.1 Sepsis, Septic Shock & Initial Fluid Resuscitation 23.2 Necrotizing Soft Tissue Infections & Severe CNS Infections 23.3 Anaphylaxis Diagnosis, Epinephrine Dosing & Airway Protection

24 Chapter 24: Metabolic, Endocrine & Electrolyte Emergencies

24.1 Diabetic Ketoacidosis & Hyperosmolar Hyperglycemic State 24.2 Critical Electrolyte Emergencies: Dyskalemias & Dysnatremias 24.3 Severe Calcium Abnormalities & Acute Adrenal Crisis

25 Chapter 25: Hematologic, Urologic & Dental Emergencies

25.1 Severe Symptomatic Anemias & Coagulopathic Emergencies 25.2 Testicular Torsion, Priapism & Acute Urinary Retention 25.3 Urgent Odontogenic Infections & Dental Trauma

26 Chapter 26: Psychiatric, Behavioral & Obstetric/Gynecologic Emergencies

26.1 Suicidal Ideation, Acute Agitation & Behavioral Emergencies 26.2 Acute Physical & Sexual Assault Care 26.3 Life-Threatening Vaginal Bleeding & Ectopic Pregnancy 26.4 Environmental Heat Stroke & Severe Hypothermia

27 Chapter 27: Acute Head, Neck & Neurologic Symptoms

27.1 Primary Acute Headaches: Migraine, Tension & Cluster 27.2 Concussion & Minor Closed Head Injury Evaluation 27.3 Transient Ischemic Attack Evaluation & ABCD2 Risk Scoring

28 Chapter 28: Acute Cranial Nerves, Hearing & Sensory Symptoms

28.1 Peripheral Neuropathies: Bell's Palsy, Carpal Tunnel & Radiculopathy 28.2 Acute Tinnitus, Sudden Sensorineural Hearing Loss & Cerumen Impaction 28.3 Acute Dizziness, Benign Paroxysmal Positional Vertigo & Vestibular Neuritis

29 Chapter 29: Acute Upper Respiratory Tract Infections

29.1 Acute Viral Rhinosinusitis vs. Bacterial Rhinosinusitis 29.2 Acute Pharyngitis: Group A Streptococcus & Centor Criteria 29.3 Acute Otitis Media, Otitis Externa & Serous Effusion

30 Chapter 30: Acute Lower Respiratory Infections & Cough

30.1 Influenza, COVID-19 & Viral Respiratory Syndromes 30.2 Acute Bronchitis & Lower Respiratory Tract Infections 30.3 Ambulatory Community-Acquired Pneumonia

31 Chapter 31: Allergic, Nasal & Non-Infectious Pulmonary Conditions

31.1 Allergic Rhinitis & Acute Non-Anaphylactic Allergic Reactions 31.2 Acute Dyspnea in Ambulatory Care 31.3 Interstitial Lung Diseases & Sarcoidosis Presentation

32 Chapter 32: Acute Chest, Cardiac & Vascular Symptoms

32.1 Palpitations Evaluation & Arrhythmia Triage in Primary Care 32.2 Deep Vein Thrombosis & Superficial Thrombophlebitis 32.3 Ambulatory Hypotension & Orthostasis Evaluation

33 Chapter 33: Acute Upper Gastrointestinal Conditions

33.1 Peptic Ulcer Disease & Gastritis 33.2 Dysphagia, Esophagitis & Acute Esophageal Disorders 33.3 Acute Nausea, Vomiting & Foodborne Illness

34 Chapter 34: Acute Lower Gastrointestinal Conditions

34.1 Acute Infectious Diarrhea & Gastroenteritis 34.2 Acute Constipation & Functional Bowel Changes 34.3 Ano-Rectal Disorders: Hemorrhoids, Fissures, Abscesses & Pruritus Ani

35 Chapter 35: Inflammatory, Functional & Malabsorptive GI Disorders

35.1 Acute Flares of Inflammatory Bowel Disease 35.2 Irritable Bowel Syndrome: Diagnosis, Subtyping & Management 35.3 Celiac Disease & Malabsorption Syndromes

36 Chapter 36: Acute Abdominal, Hepatic & Biliary Disorders

36.1 Ambulatory Abdominal & Pelvic Pain Triage 36.2 Acute Cholecystitis, Biliary Colic & Pancreatitis 36.3 Acute Liver Injury & Viral Hepatitis

37 Chapter 37: Acute Abdominal Wall, Hernias & Dental Conditions

37.1 Abdominal Wall, Inguinal & Ventral Hernias 37.2 Acute Dental Pain, Odontogenic Abscess & Aphthous Ulcers 37.3 Acute Edema: Unilateral vs. Bilateral Diagnostic Evaluation

38 Chapter 38: Acute Infectious Dermatoses

38.1 Bacterial Skin Infections: Impetigo, Cellulitis & Cutaneous Abscesses 38.2 Fungal Skin Infections: Tinea Corporis, Cruris, Pedis & Onychomycosis 38.3 Viral Cutaneous Infections: Herpes Simplex, Zoster & Molluscum Contagiosum

39 Chapter 39: Inflammatory, Allergic & Autoimmune Dermatoses

39.1 Atopic Dermatitis, Contact Dermatitis & Eczematous Flares 39.2 Non-Infectious Rashes: Urticaria, Drug Eruptions & Erythema Multiforme 39.3 Cutaneous Malignancies & Premalignant Lesions: AK, BCC, SCC & Melanoma

40 Chapter 40: Acute Shoulder, Elbow & Upper Extremity Injuries

40.1 Rotator Cuff Pathology, Tendinopathy & Shoulder Impingement 40.2 Lateral & Medial Epicondylitis, Olecranon Bursitis & Elbow Sprains 40.3 Wrist & Hand Soft-Tissue Injuries: De Quervain, TFCC & Finger Sprains

41 Chapter 41: Acute Knee, Ankle & Lower Extremity Injuries

41.1 Meniscal Tears, Ligamentous Knee Injuries & Patellofemoral Pain 41.2 Ankle Sprains, Ottawa Ankle Rules & Achilles Tendinopathy 41.3 Plantar Fasciitis, Shin Splints & Overuse Syndromes

42 Chapter 42: Acute Ambulatory Fractures & Dislocations

42.1 Distal Radius, Scaphoid & Common Upper Extremity Fractures 42.2 Metatarsal, Clavicle & Common Lower Extremity Fractures 42.3 Joint Dislocation Management: Nursemaid's Elbow & Shoulder Subluxation

43 Chapter 43: Acute Axial Musculoskeletal Pain & Falls

43.1 Acute Low Back Pain: Red Flags, Strain & Disc Herniation 43.2 Acute Cervical Strain, Whiplash & Axial Neck Pain 43.3 Evaluation of Falls in Ambulatory & Older Patients

44 Chapter 44: Acute Inflammatory Arthropathies & Generalized Pain

44.1 Acute Inflammatory Arthritis & Spondyloarthropathies 44.2 Myalgias, Rhabdomyolysis & Post-Viral Pain Syndromes 44.3 Acute Non-Headache Pain Management Strategies

45 Chapter 45: Acute Renal, Urinary & Genitourinary Conditions

45.1 Uncomplicated UTI, Pyelonephritis & Acute Urethritis 45.2 Hematuria Workup & Glomerulonephritis 45.3 Nephrolithiasis & Acute Urinary Tract Obstruction

46 Chapter 46: Acute Male Genitourinary & Prostatic Conditions

46.1 Acute Prostatitis, Epididymitis & Orchitis 46.2 Acute Scrotal Pain: Torsion vs Appendage, BPH & Male Genital Emergencies 46.3 Acute Urinary Retention & Incontinence Evaluation

47 Chapter 47: Acute Women's Health & Early Pregnancy Care

47.1 Early Pregnancy Diagnosis, Dating & Initial Complications 47.2 Abnormal Uterine Bleeding & Acute Menstrual Disorders 47.3 Premenstrual Syndrome & Premenstrual Dysphoric Disorder

48 Chapter 48: Breast Disorders, STIs & Pediatric Elimination

48.1 Palpable Breast Mass, Mastitis & Nipple Discharge 48.2 Sexually Transmitted Infections: Diagnosis, Staging & CDC Guidelines 48.3 Pediatric Enuresis & Encopresis

49 Chapter 49: Systemic Signs, Metabolic Dysregulation & Miscellaneous Infections

49.1 Acute Fever, Sepsis Screening & FUO in Primary Care 49.2 Acute Hyperglycemia & Symptomatic Hypoglycemia 49.3 Electrolyte Abnormalities: Mild-to-Moderate Disturbances 49.4 Vector-Borne, Tick-Borne & Rickettsial Illnesses

50 Chapter 50: Chronic Cardiovascular Diseases: Hypertension & Ischemia

50.1 Essential Hypertension Management: 2025 AHA/ACC Guideline & JNC Strategies 50.2 Chronic Coronary Artery Disease & Post-MI Secondary Prevention 50.3 Chronic Heart Failure: HFrEF, HFpEF & Quadruple GDMT

51 Chapter 51: Chronic Vascular, Valvular & Dyslipidemic Diseases

51.1 Peripheral Arterial Disease & Claudication 51.2 Chronic Valvular Heart Disease & Murmur Evaluation 51.3 Lipid Disorders & ASCVD Risk-Based Statin Therapy

52 Chapter 52: Chronic Respiratory Diseases: Asthma & COPD

52.1 Chronic Asthma Management: GINA Stepwise SMART Therapy 52.2 Chronic Obstructive Pulmonary Disease: GOLD Recommendations 52.3 Solitary Pulmonary Nodule Evaluation & Fleischner Society Criteria

53 Chapter 53: Chronic Metabolic Diseases: Diabetes Mellitus

53.1 Type 2 Diabetes Management: ADA Pharmacotherapy Algorithms 53.2 Type 1 Diabetes: Basal-Bolus Insulin, CGMs & Diabetic Complications 53.3 Diabetic Microvascular & Macrovascular Disease Surveillance

54 Chapter 54: Obesity, Nutrition & Metabolic Bone Diseases

54.1 Medical & Behavioral Management of Obesity & Incretin Mimetics 54.2 Osteoporosis & Metabolic Bone Disease: DEXA, FRAX & Antiresorptives 54.3 Nutritional Deficiencies: Vitamin D, B12, Iron & Malnutrition

55 Chapter 55: Chronic Endocrine Disorders

55.1 Primary & Subclinical Hypothyroidism, Hyperthyroidism & Nodules 55.2 Adrenal Disorders: Addison's Disease & Cushing's Syndrome 55.3 Hypercalcemia, Hyperparathyroidism & Pituitary Disorders

56 Chapter 56: Chronic Kidney Disease & Venous Disorders

56.1 Chronic Kidney Disease: KDIGO Staging & Renoprotective Therapy 56.2 Chronic Venous Insufficiency, Stasis Dermatitis & Lymphedema 56.3 Chronic Electrolyte & Acid-Base Management in CKD

57 Chapter 57: Chronic Gastrointestinal & Hepatic Diseases

57.1 Gastroesophageal Reflux Disease, Barrett's Esophagus & Dyspepsia 57.2 Chronic Liver Disease: MASLD/NAFLD, Cirrhosis & Portal Hypertension 57.3 Viral Hepatitis B & C: Long-Term Monitoring & DAA Therapy

58 Chapter 58: Colorectal Surveillance & Chronic Pancreaticobiliary Care

58.1 Post-Polypectomy Colorectal Polyp Surveillance Guidelines 58.2 Chronic Pancreatitis & Exocrine Pancreatic Insufficiency 58.3 Chronic Nausea, Gastroparesis & Functional GI Disorders

59 Chapter 59: Chronic Musculoskeletal & Rheumatologic Disorders

59.1 Osteoarthritis: Hip, Knee & Hand Management 59.2 Spinal Conditions: Spinal Stenosis, Spondylolisthesis & Compression Fractures 59.3 Chronic Myopathies & Fibromyalgia Syndrome

60 Chapter 60: Chronic Neurologic & Neurodegenerative Disorders

60.1 Dementia: Alzheimer's, Vascular & Lewy Body Disease 60.2 Parkinson's Disease & Essential Tremor 60.3 Epilepsy: Chronic Antiseizure Medications & Post-Stroke Care

61 Chapter 61: Chronic Peripheral Nerves, Pain & Sensory Disorders

61.1 Diabetic & Chronic Peripheral Neuropathies 61.2 Chronic Pain Syndromes & Chronic Daily Headaches 61.3 Chronic Tinnitus, Presbycusis & Persistent Dizziness

62 Chapter 62: Chronic Psychiatric Disorders

62.1 Major Depressive Disorder & Generalized Anxiety Disorder 62.2 Bipolar Disorder: Maintenance Pharmacotherapy & Lithium Monitoring 62.3 Adult & Pediatric Attention-Deficit/Hyperactivity Disorder

63 Chapter 63: Chronic Behavioral Health & Neurodevelopmental Conditions

63.1 Chronic Behavioral Conditions: PTSD, OCD & Somatization 63.2 Autism Spectrum Disorder & Intellectual Disabilities 63.3 Eating Disorders: Anorexia Nervosa, Bulimia & Binge Eating

64 Chapter 64: Chronic Substance Use Disorders & Tobacco Cessation

64.1 Alcohol Use Disorder: Pharmacotherapy & Relapse Prevention 64.2 Opioid & Stimulant Use Disorders: MOUD & Harm Reduction 64.3 Longitudinal Tobacco Cessation Pharmacotherapy

65 Chapter 65: Chronic Dermatologic Conditions

65.1 Acne Vulgaris, Rosacea & Seborrheic Dermatitis 65.2 Chronic Plaque Psoriasis & Biologic Therapies 65.3 Chronic Eczema, Hidradenitis Suppurativa & Cutaneous Lupus

66 Chapter 66: Chronic Reproductive, Infectious & Geriatric Special Care

66.1 Chronic Menstrual Disorders, Infertility & Sexual Dysfunction 66.2 Menopause Management & Hormone Replacement Therapy 66.3 Chronic HIV Infection Management & Primary Care Integration 66.4 Gender-Affirming Primary Care & Hormone Therapy 66.5 Advance Care Planning, Palliative Care & End-of-Life Symptom Control

67 Chapter 67: Continuity Care: Sleep, Fatigue, Cancer, Pregnancy & the Adult Preventive Visit

67.1 Chronic Insomnia & Obstructive Sleep Apnea 67.2 Chronic Malaise, Fatigue & ME/CFS 67.3 Primary Care During Cancer Treatment & Survivorship 67.4 Routine Prenatal Care & Longitudinal Pregnancy Management 67.5 The Periodic Adult Health Examination & Medicare Annual Wellness Visit

56.2 Chronic Venous Insufficiency, Stasis Dermatitis & Lymphedema

Key Takeaways Explain This Topic AI

Chronic venous disease arises from ambulatory venous hypertension caused by valvular reflux or deep venous obstruction; clinical severity is standardized using the CEAP classification spanning C0 (no visible signs) through C3 (edema), C4 (trophic skin changes: C4a eczema/pigmentation, C4b lipodermatosclerosis/atrophie blanche), C5 (healed ulcer), and C6 (active ulcer).

Cutaneous manifestations of chronic venous disease (CEAP C4): stasis dermatitis (C4a) presents in the gaiter distribution (medial supramalleolar calf) with pruritus, erythema, and rusty hemosiderin hyperpigmentation from extravasated RBCs; lipodermatosclerosis (C4b) is chronic sclerosing panniculitis with woody subcutaneous fibrosis producing the pathognomonic 'inverted champagne bottle' leg deformity.

Venous stasis ulcers account for 70% to 80% of all lower extremity ulcers; they are typically located over the medial malleolus, presenting as shallow, irregularly bordered lesions with a beefy red granulating bed and heavy serous exudate, with pain relieved by elevation.

Measuring the Ankle-Brachial Index (ABI) is MANDATORY prior to prescribing compression therapy: an ABI >0.8 permits full therapeutic compression (30-40 mmHg), an ABI 0.5-0.8 requires modified low-pressure compression (20-30 mmHg) with vascular co-management, and an ABI <0.5 STRICTLY CONTRAINDICATES compression due to severe arterial compromise.

Lymphedema is distinguished from venous edema by swelling over the dorsum of the foot, 'squared-off' toes, deepened skin creases, woody non-pitting induration, and a pathognomonic positive Stemmer sign (inability to tent a skin fold at the base of the second toe); true lymphedema is managed with Complete Decongestive Therapy (CDT) and is refractory to loop diuretics.

Last updated: September 2026

Chronic Venous Disease: Pathophysiology & The CEAP Classification

Chronic venous disease (CVD) is an exceedingly prevalent vascular condition affecting up to 30% to 40% of the general adult population. It encompasses a spectrum from asymptomatic cosmetic telangiectasias to debilitating chronic venous insufficiency (CVI) with intractable ulceration.

Pathophysiology of Ambulatory Venous Hypertension

In healthy individuals, the return of venous blood from the lower extremities against gravity depends on two synergistic mechanisms:

The Calf Muscle Pump : During ambulation, contraction of the gastrocnemius and soleus muscles compresses deep intramuscular venous sinusoids, propelling blood centrally toward the inferior vena cava.

Competent Bicuspid Venous Valves : Delicate endothelial valves situated throughout the superficial (great and small saphenous veins), perforating, and deep veins (femoral, popliteal, tibial veins) prevent retrograde flow during muscular relaxation. PATHOPHYSIOLOGIC CASCADE OF CHRONIC VENOUS DISEASE

• Venous Valvular Incompetence (Primary) OR Deep Vein Obstruction/DVT (Secondary)
• │
• ▼
• Failure of Calf Muscle Pump ──► Ambulatory Venous Hypertension
• (Sustained high venous pressure during active walking)
• │
• ▼
• Retrograde Transmission of Pressure to Dermal Capillary Beds
• (Capillary distension, elongation, and endothelial pore widening)
• │
• ▼
• Microvascular Extravasation of Fluid, Fibrinogen, and Red Blood Cells (RBCs)
• │
• ┌──────────────────┴──────────────────┐
• ▼ ▼
• RBC Lysis & Hemoglobin Breakdown Fibrin Cuff Formation & Leukocyte Trapping
• (Hemosiderin deposition in dermis) (Intercellular adhesion molecules [ICAM-1])
• │ │
• ▼ ▼
• Golden-Brown / Rusty Pigmentation Chronic Dermal Inflammation, Tissue Hypoxia,
• (Cutaneous Hemosiderosis) Lipodermatosclerosis & Venous Ulceration
• The CEAP Classification System

The international standard for classifying chronic venous disease is the CEAP system (Clinical, Etiologic, Anatomic, Pathophysiologic). The Clinical (C) tier correlates directly with disease severity and guides management: THE CLINICAL CEAP CLASSIFICATION

• Class Clinical Description & Physical Findings
• ═════════════════════════════════════════════════════════════════════════════════════════════
• C0 No visible or palpable signs of venous disease

C1 Telangiectasias (spider veins, < 1 mm) or Reticular veins (1 to 3 mm in diameter)

C2 Varicose veins: Dilated, tortuous, subcutaneous palpable veins >= 3 mm in diameter

C3 Edema: Dependent, pitting swelling of the ankle and leg; no trophic skin changes

C4 Trophic skin and subcutaneous changes attributable to venous disease:

• C4a: Pigmentation (hemosiderin staining) or Venous Eczema (Stasis Dermatitis)
• C4b: Lipodermatosclerosis (sclerosing panniculitis) or Atrophie Blanche

C5 Healed venous ulcer

• C6 Active venous ulcer (open, weeping skin defect)
• ═════════════════════════════════════════════════════════════════════════════════════════════

*Etiology (E): Ec (congenital), Ep (primary), Es (secondary/post-thrombotic), En (no cause).

*Anatomy (A): As (superficial), Ap (perforator), Ad (deep), An (no venous location).

*Pathophysiology (P): Pr (reflux), Po (obstruction), Pr,o (both reflux and obstruction), Pn (none).

• Clinical Manifestations: Stasis Dermatitis, Lipodermatosclerosis & Venous Ulcers
• Clinical Symptoms of Chronic Venous Insufficiency

Patients typically present with bilateral lower extremity discomfort described as a dull aching, heaviness, fullness, fatigue, or throbbing in the calves. Symptoms exhibit a characteristic circadian pattern:

Aggravating Factors : Prolonged sitting or standing, warmth, and progression toward the late afternoon or evening.

Relieving Factors : Leg elevation above the level of the heart, active walking (which engages the calf pump), and graduated compression.

Associated nocturnal calf muscle cramps and restless legs are frequent.

Stasis Dermatitis (Venous Eczema)

Stasis dermatitis represents the cutaneous inflammatory consequence of chronic microvascular hypertension and extravasation:

Distribution : Overwhelmingly localizes to the gaiter area (the lower third of the calf and medial supramalleolar region), where ambulatory venous pressure is highest.

Morphology : Erythematous, scaling, lichenified, intensely pruritic plaques. In acute flares, weeping, crusting, and superficial vesiculation occur, frequently misdiagnosed as bacterial cellulitis.

Hemosiderin Hyperpigmentation : The pathognomonic hallmark. Extravasated erythrocytes are lysed in the interstitial space, releasing hemoglobin. Dermal macrophages (histiocytes) phagocytose the iron and degrade it into hemosiderin , producing a persistent, indelible rusty, golden-brown, or ochre hyperpigmentation .

Contact Dermatitis Vulnerability : Patients with stasis dermatitis have an impaired epidermal stratum corneum barrier and develop exceptionally high rates of Type IV delayed hypersensitivity (allergic contact dermatitis) to topical agents. Sensitizing culprits include neomycin, bacitracin, lanolin, benzocaine, and fragrance additives.

Lipodermatosclerosis (LDS)

Lipodermatosclerosis (sclerosing panniculitis) is a chronic, severely debilitating complication of advanced venous insufficiency (CEAP C4b):

Pathology : Chronic venous hypertension triggers profound extravasation of macromolecular fibrinogen, creating pericapillary "fibrin cuffs" and inducing relentless fibroblastic proliferation and fat necrosis in the subcutaneous adipose tissue.

Acute Phase : Manifests as a warm, exquisitely tender, erythematous, indurated plaque on the medial lower calf. It is frequently misdiagnosed as recurrent bacterial cellulitis ("pseudo-cellulitis"). However, acute LDS is typically bilateral, afebrile, associated with normal systemic inflammatory markers (WBC, procalcitonin), and completely non-responsive to antibiotics.

Chronic Sclerotic Phase : Over months to years, progressive collagen cross-linking and subcutaneous tissue atrophy cause circumferential, woody, non-pitting induration that encases the lower calf. The fibrotic constriction strangulates the distal lower leg while proximal calf muscle remains normal or edematous, creating the classic, pathognomonic "inverted champagne bottle" or "bowling pin" deformity of the leg.

Atrophie Blanche

Represents focal dermal infarction secondary to microcirculatory thrombosis in advanced venous disease. Appears as smooth, porcelain-white, ivory, stellate atrophic plaques surrounded by hyperpigmented borders and prominent punctate, tortuous telangiectasias. These lesions are exquisitely painful and prone to break down into recalcitrant ulcers.

Venous Stasis Ulcers

Venous ulcers account for 70% to 80% of all chronic lower extremity ulcers . DIFFERENTIAL DIAGNOSIS OF LOWER EXTREMITY ULCERS

• Feature Venous Stasis Ulcer Arterial (Ischemic) Ulcer Neuropathic (Diabetic) Ulcer
• ══════════════════════════════════════════════════════════════════════════════════════════════════════════
• Primary Location Medial malleolus / Gaiter zone Distal toes, heels, bony Plantar aspect of foot,
• (lower third of medial calf) prominences, lateral ankle metatarsal heads, over calluses

• Appearance / Shallow, irregularly shaped "Punched-out", regular round Deep, punched-out crater;
• Border borders with sloping edges borders; clean, sharp margins surrounded by thick hyperkeratotic callus

• Ulcer Bed Beefy red granulation tissue Pale, gray, cyanotic base; Granular or slough; deep structures
• or yellow fibrin slough necrotic black eschar common (tendon, bone) often exposed

Exudate Heavy, copious, wet serous Dry, minimal exudate Variable (dry to purulent if infected)

• Pain Mild to moderate, dull ache; Severe, sharp pain; worse PAINLESS (complete sensory loss);
• RELIEVED by leg elevation with elevation; nocturnal loss of 10-g monofilament
• rest pain relieved by hanging
• foot over edge of bed

• Surrounding Skin Hemosiderin pigmentation, Shiny, atrophic, hairless; Dry, cracked skin, anhidrosis;
• stasis dermatitis, edema dependent rubor, pallor on Charcot foot deformity, claw toes
• elevation; cool temperature

Pulses & ABI Distal pulses normal/palpable Distal pulses absent/diminished Normal or bounding pulses; ABI may be

• ABI > 0.8 ABI <= 0.8 (Severe if < 0.5) falsely elevated (> 1.3) via calcification
• ══════════════════════════════════════════════════════════════════════════════════════════════════════════

• Diagnostic Evaluation & Evidence-Based Management Protocols
• Diagnostic Evaluation: Duplex Ultrasound & Mandatory ABI Screening

Venous Duplex Ultrasonography :

The diagnostic gold standard for evaluating chronic venous disease.

Reflux Diagnostic Criteria : Evaluates retrograde flow duration upon release of distal compression or during a Valsalva maneuver:

> 500 milliseconds (0.5 seconds) : Pathologic reflux in superficial saphenous veins, tibial veins, and deep femoral veins.

> 1,000 milliseconds (1.0 second) : Pathologic reflux in the deep femoropopliteal venous system.

> 350 milliseconds : Pathologic reflux in perforating veins.

Concurrently evaluates for acute or chronic Deep Venous Thrombosis (DVT) (luminal non-compressibility, echogenic thrombus, loss of respiratory phasicity) to rule out post-thrombotic syndrome.

The Mandatory Pre-Compression Ankle-Brachial Index (ABI) :

MANDATORY CLINICAL SAFETY RULE : An Ankle-Brachial Index (ABI) must always be obtained before initiating compression therapy on any patient with lower extremity edema, stasis dermatitis, or ulcers!

Up to 15% to 20% of patients with venous disease have coexisting, occult peripheral artery disease (mixed arterial-venous disease). Applying high-pressure compression stockings to an ischemic limb can cause complete arterial occlusion, focal pressure necrosis, acute compartment syndrome, or amputation. ABI-DIRECTED COMPRESSION SAFETY PROTOCOL

• ABI Value Arterial Status Permitted Compression Therapy Strategy
• ═════════════════════════════════════════════════════════════════════════════════════════════
• > 0.8 Normal arterial perfusion FULL Therapeutic Graduated Compression (30 to 40 mmHg)

Safe for high-pressure stockings and Unna boots.

0.5 to 0.8 Moderate arterial disease MODIFIED Low-Pressure Compression (20 to 30 mmHg)

(Mixed venous-arterial) Must be closely monitored under vascular specialist care.

< 0.5 Severe arterial disease / STRICTLY CONTRAINDICATED! Absolute contraindication to

Critical limb ischemia all external compression. Urgent vascular surgery referral.

• ═════════════════════════════════════════════════════════════════════════════════════════════
• Comprehensive Management Modalities

Compression Therapy (The Therapeutic Cornerstone) :

Compression reverses ambulatory venous hypertension by augmenting the calf muscle pump, narrowing dilated vein diameters to restore valve cusp coaptation, and driving interstitial fluid into the lymphatic system.

Graduated Knee-High Stockings :

Class 1 (20 to 30 mmHg) : Indicated for mild-to-moderate edema, symptomatic varicose veins (CEAP C2-C3), or patients unable to tolerate higher pressures.

Class 2 (30 to 40 mmHg) : The gold-standard target pressure for severe chronic venous insufficiency, active stasis dermatitis, lipodermatosclerosis, and healed venous ulcers (CEAP C4-C5) to prevent recurrence.

Application instruction: Put on first thing in the morning upon waking before dependent edema accumulates; remove at bedtime.

Unna Boot (Zinc Oxide Paste Bandage) :

Inelastic, semi-rigid gauze impregnated with zinc oxide, calamine, and gelatin .

Applied with graduated tension from the metatarsal heads to just below the tibial tuberosity, covered with an outer elastic cohesive bandage.

Delivers high working pressure during calf contraction with low resting pressure during recumbency.

Prime Indication : The first-line modality for active weeping venous stasis ulcers (CEAP C6) with heavy exudate. Changed every 3 to 7 days depending on drainage.

Leg Elevation & Physical Activity :

Instruct patients to elevate their legs above the level of the heart for 30 minutes, 3 to 4 times daily, to facilitate gravity-assisted drainage of venous blood and interstitial fluid.

Encourage regular walking, calf-raise exercises, and avoidance of prolonged standing or sitting.

Cutaneous Barrier Restoration & Dermatitis Care :

Emollient Therapy : Liberal daily application of thick, fragrance-free ointments (petroleum jelly / white petrolatum, plain mineral oil) immediately following bathing to restore stratum corneum hydration and repair lipid bilayers.

Active Eczematous Flares : Short-course (1 to 2 weeks) mid-potency topical corticosteroids ( Triamcinolone acetonide 0.1% ointment ) applied directly to inflamed, pruritic plaques. Ointment formulations are mandatory because creams contain propylene glycol and paraben preservatives that provoke contact sensitization.

The Contact Sensitizer Blacklist : Strictly avoid topical neomycin, bacitracin, lanolin, and benzocaine ! These agents trigger catastrophic allergic contact dermatitis flares mimicking cellulitis in up to 50% of CVI patients.

Systemic Pharmacotherapy & Advanced Interventions :

Pentoxifylline (400 mg PO three times daily): A xanthine derivative that improves microvascular erythrocyte deformability and reduces leukocyte adhesion; clinical trials confirm it accelerates venous ulcer healing when combined with compression.

Procedural / Surgical Interventions : Indicated when superficial saphenous reflux is documented on duplex ultrasound: Endovenous Thermal Ablation (Radiofrequency Ablation [RFA] or Endovenous Laser Ablation [EVLA]), ultrasound-guided foam sclerotherapy, and ambulatory phlebectomy to permanently eliminate superficial reflux pathways.

Lymphedema: Pathophysiology, Clinical Features & Complete Decongestive Therapy

Lymphedema is a chronic, progressive, incurable condition resulting from mechanical insufficiency or obstruction of the lymphatic transport system, leading to pathologic accumulation of protein-rich fluid in the interstitial spaces.

Etiologic Classification: Primary vs. Secondary

Primary Lymphedema (congenital hypoplasia or aplasia of lymphatic vessels):

Congenital Lymphedema (Milroy Disease) : Manifests at birth or within the first year of life; autosomal dominant mutation in the FLT4 gene encoding vascular endothelial growth factor receptor 3 (VEGFR-3).

Lymphedema Praecox (Meige Disease) : Accounts for 80% of primary cases ; typically arises around puberty or adolescence (< 35 years), with a 4:1 female predominance.

Lymphedema Tarda : Rare primary lymphedema presenting after age 35.

Secondary Lymphedema (acquired disruption of structurally normal lymphatic channels):

Worldwide Leading Cause : Lymphatic Filariasis , an endemic parasitic infection caused by the mosquito-borne nematode Wuchereria bancrofti , affecting over 120 million individuals in tropical regions.

Developed Nations Leading Cause : Oncologic Resection & Radiation : Surgical lymphadenectomy (axillary dissection in breast cancer; pelvic/inguinal lymph node dissection for prostate, cervical, endometrial, or melanoma malignancies) and regional radiation therapy.

Other Causes : Recurrent bacterial lymphangitis / erysipelas (which progressively scars lymphatic vessels), severe morbid obesity (massive localized lymphedema [BMI > 50 kg/m²]), and chronic untreated venous hypertension causing lymphatic overload failure (phlebolymphedema). CLINICAL DIFFERENTIATION OF LOWER EXTREMITY EDEMA

• Feature Chronic Venous Edema Lymphedema Lipedema
• ═════════════════════════════════════════════════════════════════════════════════════════════════════
• Etiology Venous hypertension, reflux Lymphatic transport failure Bilateral symmetrical adipose deposition

Symmetry Frequently asymmetric Often asymmetric (unilateral) BILATERAL, perfectly symmetrical

• Foot Involvement Spares dorsum of the foot; Dorsum of foot SWOLLEN; STRICT SPARING of the foot;
• edema stops at ankle "buffalo hump"; squared toes "cuff" sign at malleoli

Stemmer Sign NEGATIVE POSITIVE (Pathognomonic!) NEGATIVE

• Pitting Nature Pitting (soft) Pitting in early stages; NON-PITTING; soft, tender, painful fat
• brawny non-pitting later

• Skin Texture Hemosiderin pigmentation, Peau d'orange, woody fibrosis, Bruises easily; telangiectasias;
• stasis dermatitis, ulcers hyperkeratosis, lichenification no hemosiderosis or ulcers

• Diuretic Response Moderate reduction in volume NO EFFECT (Ineffective!) NO EFFECT
• ═════════════════════════════════════════════════════════════════════════════════════════════════════
• Clinical Hallmark: The Stemmer Sign & Physical Exam Features

The Dorsal Foot "Buffalo Hump" : Unlike venous edema (which pools in the perimalleolar ankle), lymphedema characteristically involves the dorsum of the foot , giving it a full, rounded, dome-like appearance.

"Squared-Off" Toes ("Sausage Digits") : Persistent edema between the digits blunts normal anatomical tapering, causing the second, third, and fourth toes to appear square, separated by deep transverse cutaneous creases.

The Pathognomonic Stemmer Sign :

Technique : The examiner attempts to pinch and lift a fold of skin at the dorsal base of the second toe.

Positive Stemmer Sign : The examiner is unable to pinch or tent the skin fold because the dermis is thickened, fibrotic, and tightly bound by dense interstitial proteinaceous edema.

Clinical Value : A positive Stemmer sign is virtually 100% specific for lymphedema! (A negative sign does not exclude early, mild disease).

Skin Evolution : Begins as soft, dependent pitting edema (Stage 1), but inexorably progresses into woody, brawny non-pitting induration (Stage 2) with epidermal hyperkeratosis, verrucous cobblestone papules, and a coarse peau d'orange (orange-peel) texture (Stage 3, lymphostatic elephantiasis).

Complete Decongestive Therapy (CDT): The Standard of Care

True lymphedema is a chronic mechanical failure that cannot be resolved by pharmacotherapy :

The Diuretic Rule : Systemic loop diuretics (furosemide) are INEFFECTIVE for true lymphedema ! Diuretics remove water from the vascular compartment without clearing high-molecular-weight proteins from the interstitial space. Chronic diuretic therapy depletes intravascular volume, activates the renin-angiotensin axis, promotes electrolyte wasting, and concentrates interstitial protein, thereby accelerating dense fibroblastic sclerosis.

Complete Decongestive Therapy (CDT) Protocol :

Phase 1: Intensive Decongestion Phase (Active Reduction) :

Manual Lymphatic Drainage (MLD) : A specialized, light, rhythmic manual massage technique that stimulates lymphangion peristalsis and redirects fluid along superficial collateral lymphatic channels toward functional regional nodal basins.

Multilayer Short-Stretch Bandaging : Uses non-elastic bandages that provide low resting pressure (comfortable at rest) and high working pressure (provides a rigid wall during muscle contraction, maximizing lymphatic pumping).

Remedial Decongestive Exercises : Low-impact movements performed while wearing bandages to activate the muscle pump.

Meticulous Skin Hygiene : Cleansing and emollient care to prevent epidermal cracks and bacterial portal-of-entry.

Phase 2: Lifelong Maintenance Phase :

Daytime wear of high-grade flat-knit graduated compression garments (Class 3: 30 to 40 mmHg or Class 4: 40 to 50 mmHg).

Nighttime bandaging or intermittent pneumatic compression devices, daily skin care, and prompt treatment of any cellulitis flare.

Loading diagram... Clinical Diagnostic & Treatment Algorithm for Lower Extremity Venous Disease vs Lymphedema